Ping An Biomedical announces extraordinary general meeting of shareholders
PASW•Ping An Biomedical will hold an extraordinary general meeting in Hong Kong on October 29, 2026, where shareholders will vote on a 40-for-1 share consolidation and a proposal to increase authorized share capital from USD 312,500 to USD 12.5 million.
1. Shareholder proposals
The 40-for-1 consolidation of class A and class B ordinary shares is set to take effect on October 23, 2026. Shareholders will also consider further proposed consolidations ranging from 10-for-1 to 80-for-1, depending on class A ordinary share closing prices below USD 1, and related amendments to the company's memorandum and articles of association.
